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ABSTRACT
Background: Mercury is a highly toxic environmental metal that exists in three different forms: elemental, inorganic and organic. Intoxication 
occurs in either occupational or non-occupational settings, mainly after the inhalation of vapour and fumes in work places, laboratories or 
homes. Chronic mercury toxicity ranges from mild and insignificant to severe and life-threatening. We describe the case of a young male 
patient who presented with multiple organ dysfunction after chronic mercury exposure. 
Case presentation: We report the case of 28-year-old male artisanal gold miner who was admitted to hospital for severe neurological 
impairment associated with inflammatory bowel disease-like symptoms and a skin rash after mercury exposure. Symptomatic treatment 
and corticosteroid administration assured rapid clinical improvement. Chronic mercury poisoning can masquerade as an autoimmune or 
systemic inflammatory disease. 
Conclusion: Physicians should be aware that low exposure to mercury, even from artisanal gold mining, may be harmful to health. Management 
can be simple without the need for aggressive or invasive therapeutic measures. Larger case series are required in order to establish a clear 
management plan.
LEARNING POINTS
• Mercury intoxication has a wide the variety of clinical manifestations that may involve the neurological, gastrointestinal and 
dermatological systems.
• Therefore, it can mimic degenerative neurological conditions, autoimmune diseases, as well as metabolic and mitochondrial disorders.
• Once diagnosed, mercury intoxication is easily treated.
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INTRODUCTION
Mercury is a highly toxic environmental metal that exists in three different forms: elemental, inorganic (mercuric salts, e.g. mercuric 
chloride) and organic (e.g. methylmercury)[1,2]. It exhibits several patterns of toxicity depending on the chemical form and route of exposure. 
Intoxication occurs in either occupational or non-occupational settings, mainly after inhalation of vapour and fumes in work places, 
laboratories or homes[2]. Inorganic mercury can only be absorbed by the gastrointestinal tract and skin, while organic mercury can be 
absorbed by the gastrointestinal tract, skin and respiratory system[1–3].
Chronic mercury toxicity ranges from mild and insignificant to severe and life-threatening, inducing a wide array of clinical manifestations. 
The central nervous system, gastrointestinal tract, kidneys, skin and mucosae can be affected[3].
We report the case of a young male patient who was admitted to hospital for severe neurological impairment associated with inflammatory 
bowel disease-like symptoms and a skin rash after mercury exposure. 
CASE DESCRIPTION
A 28-year-old male was admitted to our hospital with a 3-month history of low-grade fever, severe insomnia, behavioural changes, visual 
hallucinations, recent hearing difficulty and unintentional 12 kg weight loss. His past medical history was notable for slowly progressive 
ataxia along with lower limb paraesthesia, burning sensations and muscular fasciculations, followed by the sensation of incomplete bladder 
voiding, erectile dysfunction and urinary retention. He had also developed a pruritic cutaneous rash with palmoplantar scaling and severe 
spasmodic abdominal pain accompanied by bloody diarrhoea. Previous investigations had excluded infectious, metabolic, neurological 
and mitochondrial pathologies. The patient had started working 6 months previously in Liberia at an artisanal gold mine with exposure to 
mercury-gold amalgam. He did not report any contact allergies, at-risk sexual activities or relevant family history. 
On physical examination, the patient was stable. His blood pressure was 110/65 mmHg, body temperature 38°C, pulse rate 102 beats/
minute and respiratory rate 20 breaths/minute. He was conscious, cooperant and oriented but easily became agitated and irritable. Heart 
beats were regular, lungs were clear, and the abdomen was tender in the right lower quadrant without any other abnormalities. Neurological 
examination showed a severe ataxic gait, an absence of deep tendon reflexes, and diffuse muscle fasciculations mainly in the lower limbs. 
He had no motor weakness or sensory disturbance. The rest of the neurological examination was normal. Skin examination showed an 
erythematous macular rash with multiple excoriations on the trunk and some pustules on the back and chest, along with excoriated papules 
and pustules on the back, axillae and periumbilical area (Fig. 1). We noted a clearly demarcated incision on the patient’s back that had been 
made to allow bloodletting, which in traditional African medicine is believed to help eliminate toxins from the blood. In addition, palmoplantar 
desquamation was prominent (Fig. 2). No other pathological findings were observed on physical examination, ruling out lymphadenopathies, 
arthritis and testis anomalies.
Figure 1. Excoriated papules in the periumbilical area and on the back
Laboratory tests results showed mild leukocytosis (neutrophils 72%) and normal haemoglobin and platelet levels, erythrocyte sedimentation 
rate, C-reactive protein, liver function tests, lactate dehydrogenase, kidney function, and biochemistry profile except for mild hypokalaemia 
(3.1 mEq/l). Urine analysis showed 80 white blood cells (WBC), 70 red blood cells (RBC), with sterile culture and proteinuria of 1.125 g/day.
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Figure 2. Palmoplantar desquamation
An extensive serology workup showed negative Weil-Felix, Wright, Widal and venereal disease research laboratory (VDRL) tests, a 
negative Treponema pallidum hemagglutination assay (TPHA), and negative tests for hepatitis B virus (HBV), hepatitis C virus (HCV), human 
immunodeficiency virus (HIV) 1 and 2, and malaria. The immunological profile showed normal levels of antinuclear antibodies (ANA), C3, 
C4, anti-thyroid-stimulating hormone (TSH) receptor antibodies and normal serum immunoelectrophoresis. A purified protein derivative 
(PPD) skin test was negative. Tests for vitamin B12, TSH and ceruloplasmin were all within normal limits. Culture of skin pustule content was 
sterile. A lumbar puncture showed no abnormalities.
An electrocardiogram (EKG) showed sinus tachycardia. Chest x-ray was normal. Cerebral, pituitary and dorso-lumbar magnetic resonance 
imaging (MRI) was normal. Abdominal and pelvic ultrasound revealed chronic cystitis and a thickened bladder wall. Electromyography 
showed generalized muscular fasciculations due to toxic, metabolic or endocrine causes. A neuromuscular biopsy was unremarkable, while 
a skin biopsy specimen from a pustule on the back showed non-specific mild chronic dermatitis. Colonoscopy demonstrated mild ileitis and 
histopathology disclosed granulomatous lesions suggestive of Crohn's disease or other mimicking diseases.
In accordance with the patient’s clinical picture and risk of severe occupational exposure to heavy metals, plasma levels showed high 
concentrations of mercury at 8.83 µg/l or 44 nmol/l (normal level <5 µg/l or <25 nmol/l), chrome at 1.23 µg/l (normal level <0.87 µg/l) and 
nickel at 2.5 µg/l (normal level <1.3 µg/l), while other metals were within the normal range. 
A diagnosis of heavy metal intoxication was made. The patient was started on a high-dose corticosteroid (80 mg methylprednisolone per 
day) for 2 weeks followed by dose tapering over 2 months. His hospital course was uneventful with a smooth recovery. The patient was 
discharged with regular follow-up in the outpatient clinic. A remarkable improvement in the ataxia and other neurological complaints and 
gastrointestinal symptoms was noted at follow-up 2 months after corticosteroid cessation. One year later, the patient is asymptomatic and 
did not resume his work as an artisanal gold miner.
DISCUSSION
Heavy metal intoxication developed as a major healthcare problem especially after the industrial revolution. Elemental mercury is still 
widely used in industrial facilities, households, and in medical and electrical devices (thermometers, thermostats, electrical switches, dental 
amalgam)[4]. It is also used in artisanal small-scale gold mining[4] where gold extraction using archaic and unsafe methods predisposes miners 
to mercury poisoning mainly through inhalation as in our patient.
Mercury is a toxin that eventually affects cellular physiology and haemostasis. Toxicity varies depending on the form of mercury, dose, rate 
of exposure and the pharmacokinetic characteristics of each form[1,3,5]. Mercury vapour inhalation mainly affects the brain, while inorganic 
mercury and methylmercury primarily affect the intestinal mucosae and kidneys[1]. Acute exposure to elemental mercury vapour can cause 
severe pneumonitis[1]. Clinical findings are systemic and more subtle in chronic exposure.
Mercury poisoning poses a diagnostic challenge. Firstly, the blood toxicity threshold has been debated. Graeme et al. considered that a blood 
level above 15 g/l indicated mercury toxicity[6], while Dantzig found that a level as low as 6 g/l or less may be toxic[7]. Hence, symptoms may 
be present at low levels of exposure[8,9]. Secondly, there are no defined criteria for the diagnosis of mercury poisoning since there is no clear 
correlation between clinical symptoms of intoxication and the level of mercury in the body[3,8,9]. 
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However, Doering et al. defined 10 indicators to assess mercury exposure in gold miners based on a medical score and on increased mercury 
levels in blood, hair and urine[10]. However, no definitive standard for the diagnosis of chronic mercury intoxication has yet been established. 
The soluble characteristics of elemental mercury make it highly diffusible and capable of passing through cell membranes as well as the 
blood–brain barrier to reach target organs[1]. The central nervous system is thought to be the organ most affected by chronic exposure 
to elemental mercury. Vapour containing elemental mercury is absorbed easily by the lungs and then reaches the blood–brain barrier[11]. 
Mercury has been identified as a neurotoxin that damages the cerebellum[10]. At low levels of exposure, non-specific symptoms occur 
such as anorexia, weight loss, weakness, fatigue and headaches[9]. At high levels of exposure, the many clinical symptoms include muscle 
fasciculations, polyneuropathy with neuromuscular changes on electromyography, an abnormal Romberg test, dysdiadochokinesis and 
difficulty with heel-to-toe gait. Cognitive impairment has also been reported, with behavioural and personality changes, poor concentration, 
emotional lability, memory loss, depression, insomnia, delirium and hallucinations[3,9]. Strict avoidance of exposure may induce regression of 
some symptoms but with persistence of some others depending on the concentration and duration of exposure[3]. Our patient had severe 
neurological symptoms that completely regressed after gold mining cessation.
Elemental mercury is excreted by the kidneys where it can accumulate and cause renal damage[11]. Mercury vapour may cause mild transient 
proteinuria as observed in our case, but can also induce frank proteinuria, haematuria, albumin excretion and oliguria by targeting the 
proximal convoluted tubules[3]. Decreased renal output and renal failure have also been reported with long-term exposure[3,11]. 
Cutaneous manifestations are well described with inhalation and with oral and direct dermal exposure to mercury[3]. Both systemic and 
topical contact may provoke allergic contact dermatitis (ACD), which is the most common skin reaction to mercury. ACD is characterized by 
painful or mildly pruritic eczematous eruptions[7]. Prolonged exposure to elemental mercury may cause acrodynia (formerly referred to as 
Pink disease), but it is restricted to infants and young children[11]. Dermal exposure can result in erythematous and peeling skin on the palms 
and soles[3]. Inhalation of mercury vapour can within a few days also cause acute generalized exanthematous pustulosis, an erythematous 
maculopapular rash with small sterile non-follicular pustules. Eruption usually begins in the proximal extremities and flexural areas and 
then becomes diffuse and symmetric. Significant desquamation can also be seen on the hands and feet, followed by spontaneous complete 
resolution 2 weeks later. Most probably, this was the type of cutaneous mercury toxicity seen in our patient, along with palmoplantar 
desquamation.
Gastrointestinal manifestations have been reported after ingestion of inorganic mercury which, unlike elemental mercury, is easily absorbed 
by the gut[11]. Inorganic mercury is corrosive to the gastrointestinal tract, causing stomatitis, excessive salivation, severe abdominal pain, 
diarrhoea, nausea, vomiting, ulceration and haemorrhagic lesions[3, 11]. 
Low exposure to mercury has been reported to play a role in immune system dysregulation[12, 13]. It may trigger autoimmune diseases such 
as systemic lupus erythematosus and multiple sclerosis[14–16]. An aberrant immune response resulting in inflammatory bowel disease-like 
lesions has been associated with mercury intoxication[12]. Heis et al. reported a case of unexplained haemorrhagic colitis after acute mercury 
exposure in a patient without a history of inflammatory bowel disease[12]. 
The concomitant presentation in our patient of neurological, cutaneous and gastrointestinal clinical findings that completely disappeared 
after cessation of exposure suggests that granulomatous ileitis could be related to systemic mercury intoxication rather than Crohn's 
disease. Further studies are needed to confirm the potential role of mercury in granulomatous ileitis.
The management of elemental mercury poisoning is not well defined. Treatment modalities that may be helpful include specific therapy 
such as chelation (e.g. dimercaprol, succimer, unithiol, penicillamine) or non-specific therapeutic measures such as intravenous hydration 
and symptomatic treatment[4]. In our case, the patient received a systemic corticosteroid with significant clinical improvement. Whether 
steroids play a specific role in mercury intoxication treatment or reduce systemic inflammation requires further research and investigation.
CONCLUSION
In our patient, chronic mercury exposure induced many clinical anomalies due to the simultaneous and severe involvement of multiple 
organs. Symptomatic treatment and corticosteroid administration ensured rapid clinical improvement.
Chronic mercury poisoning could masquerade as an autoimmune or systemic inflammatory disease. Hence, physicians should be aware 
that low exposure to mercury, even from artisanal gold mining, might be harmful to health. Management can be simple without the need for 
aggressive or invasive therapeutic measures. Large case series are required in order to establish a clear management plan.
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